This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AEZS at https://www.zacks.com/ap/AEZS Keywords: Aeterna Zentaris, …
Yahoo!9mon
Aeterna Zentaris Inc. (NASDAQ:AEZS) (TSX:AEZS) (the “Company”) announced today ... sell up to a maximum of 3,000,000 common shares through ATM issuances on the NASDAQ Stock Market, up to an aggregate amount of $9.0 …
Aeterna says AEZS-108 does less damage to healthy tissue than existing treatments. Disappointing trial results for another cancer drug, perifosine, have weighed heavily on Aeterna’s stock this year, and in October it consolidated its …
The company had no specific news. Aeterna Zentaris Inc. (NASDAQ: AEZS) dropped about 36% on Thursday to post a new 52-week low of $2.35 after closing at $3.65 on Wednesday. The stock’s 52-week high is $5.59. Volume was about …
Coming up in Burdwan district, one of the states four designated agri-export zones (AEZs), the venture between Amazan Agro ... crop is processed and only 30 per cent sold as fresh table stock, Indian farmers have to deal with distress …
Aeterna Zentaris Inc is a specialty biopharmaceutical company engaged in developing and commercializing treatments in oncology, endocrinology and women's health. The Company operates through the biopharmaceutical segment. The …
A year ago, they were trading at $3.25. This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AEZS at https://www.zacks.com/ap/AEZS